
Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025

I'm PortAI, I can summarize articles.
Vcanbio Cell & Gene Engineering Corp., Ltd reported its earnings for the nine months ending September 30, 2025. Sales decreased to CNY 1,092.46 million from CNY 1,205.9 million year-over-year. Net income fell to CNY 107.91 million from CNY 133.51 million. Basic and diluted earnings per share from continuing operations were both CNY 0.24, down from CNY 0.29 a year ago.

